2010
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: pooled analysis of 3-year clinical outcomes from the Spirit II and III Trials
Lansky A, Hermiller J, Applegate R, Caixeta A, Gordon P, Ruygrok P, Doostzadeh J, Miquel-Hebert K, Veldhof S, Sood P, Su X, Sudhir K, Serruys P, Stone G. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: pooled analysis of 3-year clinical outcomes from the Spirit II and III Trials. Cardiovascular Revascularization Medicine 2010, 11: 277. DOI: 10.1016/j.carrev.2010.03.028.Peer-Reviewed Original Research
2005
Randomized comparison of carbon ion–implanted stent versus bare metal stent in coronary artery disease: The Asian Pacific Multicenter Arthos Stent Study (PASS) trial
Kim YH, Lee CW, Hong MK, Park SW, Tahk SJ, Yang JY, Saito S, Santoso T, Quan L, Ge J, Weissman NJ, Lansky AJ, Mintz GS, Park SJ. Randomized comparison of carbon ion–implanted stent versus bare metal stent in coronary artery disease: The Asian Pacific Multicenter Arthos Stent Study (PASS) trial. American Heart Journal 2005, 149: 336-341. PMID: 15846274, DOI: 10.1016/j.ahj.2004.02.018.Peer-Reviewed Original ResearchConceptsMajor adverse cardiac eventsAngiographic restenosis rateLong-term outcomesLate lossRestenosis rateGroup 2Group 1Adverse cardiac eventsNative coronary lesionsNonfatal myocardial infarctionCoronary artery diseaseMulticenter clinical studyLesion revascularizationPrimary endpointSecondary endpointsBaseline characteristicsCardiac eventsArtery diseaseCoronary lesionsHospital eventsRandomized comparisonBare metalMyocardial infarctionClinical studiesInflammatory reaction